Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo

Background: Vitiligo is a skin autoimmune disease that affects 0.1% to more than 8% of people in the world. About 50% of patients develop the disease before the age of 20. In this disease, melanocytes are destroyed in the skin, mucous membranes and retina. As a result, white spots appear on differen...

Full description

Bibliographic Details
Main Authors: Mina Mir Nezami, Hamid Hamidi, Saeed Karimi Motaleb
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2022-07-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://tumj.tums.ac.ir/article-1-11810-en.html
_version_ 1811313987812327424
author Mina Mir Nezami
Hamid Hamidi
Saeed Karimi Motaleb
author_facet Mina Mir Nezami
Hamid Hamidi
Saeed Karimi Motaleb
author_sort Mina Mir Nezami
collection DOAJ
description Background: Vitiligo is a skin autoimmune disease that affects 0.1% to more than 8% of people in the world. About 50% of patients develop the disease before the age of 20. In this disease, melanocytes are destroyed in the skin, mucous membranes and retina. As a result, white spots appear on different parts of the body. Studies have suggested the role of oxidative stress in vitiligo. Coenzyme Q10 is a specific lipophilic antioxidant. The aim of this study was to evaluate the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo. Methods: This study was a randomized, double-blind, clinical trial of patients with generalized vitiligo who had been referred to the dermatology clinics of Vali-e-Asr Hospital and Imam Reza Clinic in May-August 2016. The sampling method was random. Patients were treated with standard treatment, and the case groups in addition to standard treatment with tablets containing coenzyme Q10. Patients were evaluated for response at the first visit, 1 and 3 months after the start of treatment. Results: The mean age of 50 patients was 26.2±4.3 years. The diameter of the largest depigmented patch decreased in both intervention (P=0.000) and control (P=0.001) groups during 3 months of treatment. The difference in the frequency of patients in the grade of repigmentation was significant at the end of the third month compared to the end of the first month of treatment in both intervention (P=0.01) and control (P=0.02) groups. At the end of the third month, the frequency of patients in both intervention group with 21 patients (76%) and the control group with 18 patients (72%) were more in grades 1 and 2, while at the end of the first month, the frequency of patients in both intervention groups with 23 patients (92%) and control with 23 patients (92%) was more in grades 0 and 1. Conclusion: Adjuvant therapy with oral coenzyme Q10 has no effect on improving depigment patch in vitiligo.
first_indexed 2024-04-13T11:04:04Z
format Article
id doaj.art-282bddbb218c4dffb1e9bafbb08c8104
institution Directory Open Access Journal
issn 1683-1764
1735-7322
language fas
last_indexed 2024-04-13T11:04:04Z
publishDate 2022-07-01
publisher Tehran University of Medical Sciences
record_format Article
series Tehran University Medical Journal
spelling doaj.art-282bddbb218c4dffb1e9bafbb08c81042022-12-22T02:49:19ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222022-07-01804286292Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligoMina Mir Nezami0Hamid Hamidi1Saeed Karimi Motaleb2 Background: Vitiligo is a skin autoimmune disease that affects 0.1% to more than 8% of people in the world. About 50% of patients develop the disease before the age of 20. In this disease, melanocytes are destroyed in the skin, mucous membranes and retina. As a result, white spots appear on different parts of the body. Studies have suggested the role of oxidative stress in vitiligo. Coenzyme Q10 is a specific lipophilic antioxidant. The aim of this study was to evaluate the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo. Methods: This study was a randomized, double-blind, clinical trial of patients with generalized vitiligo who had been referred to the dermatology clinics of Vali-e-Asr Hospital and Imam Reza Clinic in May-August 2016. The sampling method was random. Patients were treated with standard treatment, and the case groups in addition to standard treatment with tablets containing coenzyme Q10. Patients were evaluated for response at the first visit, 1 and 3 months after the start of treatment. Results: The mean age of 50 patients was 26.2±4.3 years. The diameter of the largest depigmented patch decreased in both intervention (P=0.000) and control (P=0.001) groups during 3 months of treatment. The difference in the frequency of patients in the grade of repigmentation was significant at the end of the third month compared to the end of the first month of treatment in both intervention (P=0.01) and control (P=0.02) groups. At the end of the third month, the frequency of patients in both intervention group with 21 patients (76%) and the control group with 18 patients (72%) were more in grades 1 and 2, while at the end of the first month, the frequency of patients in both intervention groups with 23 patients (92%) and control with 23 patients (92%) was more in grades 0 and 1. Conclusion: Adjuvant therapy with oral coenzyme Q10 has no effect on improving depigment patch in vitiligo.http://tumj.tums.ac.ir/article-1-11810-en.htmlcoenzyme q10oxidative stressvitiligo.
spellingShingle Mina Mir Nezami
Hamid Hamidi
Saeed Karimi Motaleb
Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo
Tehran University Medical Journal
coenzyme q10
oxidative stress
vitiligo.
title Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo
title_full Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo
title_fullStr Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo
title_full_unstemmed Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo
title_short Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo
title_sort evaluation of the therapeutic effect of coenzyme q10 in patients with generalized vitiligo
topic coenzyme q10
oxidative stress
vitiligo.
url http://tumj.tums.ac.ir/article-1-11810-en.html
work_keys_str_mv AT minamirnezami evaluationofthetherapeuticeffectofcoenzymeq10inpatientswithgeneralizedvitiligo
AT hamidhamidi evaluationofthetherapeuticeffectofcoenzymeq10inpatientswithgeneralizedvitiligo
AT saeedkarimimotaleb evaluationofthetherapeuticeffectofcoenzymeq10inpatientswithgeneralizedvitiligo